ArticlePlastic and reconstructive surgery. Global open2025
Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aligning opioid prescribing with patient needs is important for managing pain while minimizing risks. However, little is known about opioid prescribing after gender-affirming procedures. Given that gender-diverse patients are at higher risk for poor opioid-related outcomes, creating guidelines centered on patient-reported opioid use and pain experiences is critical. We conducted a prospective survey study examining opioid prescribing and consumption after gender-affirming mastectomy (GAM). Methods: Patients who underwent GAM from February to September 2021 were identified. Electronic medical record data were collected, including opioid prescription and refill amounts. Patient-reported outcomes including opioid use, nonopioid adjunct use, pain rating 1 week postoperatively, and pain management satisfaction were collected via telephone surveys 2-4 weeks postoperatively. Descriptive statistics and bivariate analyses compared outcomes between opioid consumers and nonconsumers. Results: Of 115 patients, 72 responded with complete data (62.6% response rate). Sixty-three individuals (87.5%) consumed opioids and 9 (12.5%) did not consume opioids. The median (interquartile range) opioid prescription quantity was 15 (12-17) tablets. The median (interquartile range) consumption was 10 (3-14.5) tablets ( Conclusions: Most patients undergoing GAM reported using opioids, with an average of 10 pills, and were satisfied with their postoperative pain control. Going forward, surgeons should consider tailoring prescribing to patient needs and providing nonopioid alternatives when possible.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.